Press Releases

RIDGEFIELD, Conn., Sept. 30, 2019 /PRNewswire/ -- Boehringer Ingelheim announced today that in the Phase III INBUILD® trial Ofev® (nintedanib) slowed lung function decline by 57% across the overall study population, as assessed by the annual rate of decline in forced vital capacity (FVC) over 52 weeks in patients with fibrosing interstitial lung disease

WALTHAM, Mass., Sept. 30, 2019 /PRNewswire/ -- Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, announced that it will release its financial results for the third quarter of 2019 before the market opens on Wednesday, October 23, 2019, and will hold a conference call on the same day at 8:30 a.m. EDT

SALT LAKE CITY, Sept. 30, 2019 /PRNewswire/ -- Lipocine Inc. (NASDAQ: LPCN), a clinical-stage biopharmaceutical company focused on metabolic and endocrine disorders, today announced that the first patient has been dosed in its LiFT ("Liver Fat intervention with oral Testosterone") Phase 2 clinical study, a paired-biopsy study in confirmed pre-cirrhotic non-alcohol

JACKSONVILLE, Fla., Sept. 30, 2019 /PRNewswire/ -- Johnson & Johnson Vision† is excited to unveil the first-ever extension of the ACUVUE® brand name beyond contact lenses with today's launch of ACUVUE™ RevitaLens Multi-Purpose Disinfecting Solution (MPDS). ACUVUE™ RevitaLens MPDS delivers exceptional disinfection and all-day comfort for

MAPLE GROVE, Minn., Sept. 30, 2019 /PRNewswire/ -- 4C Medical Technologies, Inc., the creator of a new generation of therapies for structural heart disease, announced today that its medical device therapy for mitral regurgitation (MR), AltaValve™, was featured at Transcatheter Cardiovascular Therapeutics (TCT) 2019, on Sept

PHOENIX, Sept. 30, 2019 /PRNewswire/ -- Pet parents who work out with their dog are getting 25% more exercise than those who don't, according to a new national online survey* commissioned by PetSmart, North America's largest pet specialty retailer. The survey collected data from 1,520 U.S. pet parents surveyed between

NORTHBROOK, Ill., Sept. 30, 2019 /PRNewswire/ -- Astellas Pharma US, Inc. ("Astellas") today announced the finalists for its fourth annual C3 (Changing Cancer Care) Prize, a challenge that funds the best ideas beyond medicine to improve cancer care for patients, caregivers and their loved ones. The C3 Prize will award up to

MAPLE GROVE, Minn., Sept. 30, 2019 /PRNewswire/ -- Pursuit Vascular, Inc., manufacturer of ClearGuard® HD Antimicrobial Barrier Caps, today announced it will be exhibiting at this week's National Renal Administrators Association (NRAA) 2019 Annual Conference.

Results show superiority and desired differentiation from competing IL-2 programs TORONTO, Sept. 30, 2019 /PRNewswire/ - Medicenna Therapeutics Corp.  ("Medicenna" or "the Company") (TSX: MDNA, OTCQB: MDNAF), a clinical stage immunotherapy company developing first-in-class Superkines and Empowered Cytokines, an

DUBLIN, Sept. 30, 2019 /PRNewswire/ -- Endo International plc ("Endo") (NASDAQ: ENDP) today announced the successful culmination of two litigation matters before the U.S. District Court for the District of Columbia regarding the unlawful compounding of vasopressin from bulk drug substances.In October 2017, Endo initiated